Search research articles
Contact Us
Filters
Showing results (121-130 of 161) with videos related to
Page
of 17
Sort By:
Schweizerische Medizinische Wochenschrift
|
May 16, 1987
[Hodgkin's disease in a Swiss family]
M F Fey, R A Joss, W J Pichler, et al.
Archives of Gynecology and Obstetrics
|
November 28, 2017
Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part I: Indications for fertility preservation
A N Schüring, T Fehm, K Behringer, et al.
International Journal of Cancer
|
September 30, 1992
Prevalence of the Rhesus-negative phenotype in Caucasian patients with small-cell lung cancer (SCLC)
T Cerny, M F Fey, R Oppliger, et al.
Oncogene
|
February 2, 1999
Aberrant FHIT mRNA transcripts are present in malignant and normal haematopoiesis, but absence of FHIT protein is restricted to leukaemia
U R Peters, U Hasse, E Oppliger, et al.
The Prostate
|
June 1, 1997
Abnormal p53 expression is rare in clinically localized human prostate cancer: comparison between immunohistochemical and molecular detection of p53 mutations
A E Mottaz, R Markwalder, M F Fey, et al.
Oncogene
|
May 23, 2006
Targeting survivin via PI3K but not c-akt/PKB by anticancer drugs in immature neutrophils
S Martinelli, G Kostylina, V Niggli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: does quality of life matter?
J Bernhard, B Thürlimann, S F Schmitz, et al.
Blood
|
February 15, 1994
Clonality and X-inactivation patterns in hematopoietic cell populations detected by the highly informative M27 beta DNA probe
M F Fey, S Liechti-Gallati, A von Rohr, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1994
High incidence of infections after 2-chlorodeoxyadenosine (2-CDA) therapy in patients with malignant lymphomas and chronic and acute leukaemias
D C Betticher, M F Fey, A von Rohr, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 26, 1999
Quality of life in postmenopausal patients with breast cancer after failure of tamoxifen: formestane versus megestrol acetate as second-line hormonal treatment. Swiss Group for Clinical Cancer Research (SAKK)
J Bernhard, M Castiglione-Gertsch, S F Schmitz, et al.
Page
of 17
Search research articles
Search
Showing results (121-130 of 161) with videos related to
Sort By:
Page
of 17
Schweizerische Medizinische Wochenschrift
|
May 16, 1987
[Hodgkin's disease in a Swiss family]
M F Fey, R A Joss, W J Pichler, et al.
Archives of Gynecology and Obstetrics
|
November 28, 2017
Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part I: Indications for fertility preservation
A N Schüring, T Fehm, K Behringer, et al.
International Journal of Cancer
|
September 30, 1992
Prevalence of the Rhesus-negative phenotype in Caucasian patients with small-cell lung cancer (SCLC)
T Cerny, M F Fey, R Oppliger, et al.
Oncogene
|
February 2, 1999
Aberrant FHIT mRNA transcripts are present in malignant and normal haematopoiesis, but absence of FHIT protein is restricted to leukaemia
U R Peters, U Hasse, E Oppliger, et al.
The Prostate
|
June 1, 1997
Abnormal p53 expression is rare in clinically localized human prostate cancer: comparison between immunohistochemical and molecular detection of p53 mutations
A E Mottaz, R Markwalder, M F Fey, et al.
Oncogene
|
May 23, 2006
Targeting survivin via PI3K but not c-akt/PKB by anticancer drugs in immature neutrophils
S Martinelli, G Kostylina, V Niggli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: does quality of life matter?
J Bernhard, B Thürlimann, S F Schmitz, et al.
Blood
|
February 15, 1994
Clonality and X-inactivation patterns in hematopoietic cell populations detected by the highly informative M27 beta DNA probe
M F Fey, S Liechti-Gallati, A von Rohr, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1994
High incidence of infections after 2-chlorodeoxyadenosine (2-CDA) therapy in patients with malignant lymphomas and chronic and acute leukaemias
D C Betticher, M F Fey, A von Rohr, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 26, 1999
Quality of life in postmenopausal patients with breast cancer after failure of tamoxifen: formestane versus megestrol acetate as second-line hormonal treatment. Swiss Group for Clinical Cancer Research (SAKK)
J Bernhard, M Castiglione-Gertsch, S F Schmitz, et al.
Page
of 17